Back to results
US 8,617,577 B2Granted
Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
AssigneePondera Biotechnologies, LLC
InventorsSteven Crain, William E. Crain, Stanley M. Crain, Michael Crain
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and compositions for reducing distress dysfunction, including emotional and physical distress. The invention entails co-administration of at least one Receptor Switcher and at least one Endorphin Enhancer. Additionally, at least one Synergistic Enhance and/or at least one Exogenous Opioid are also administered to enhance or prolong the therapeutic effects.
Claims6
A method to safely and effectively treat asthma or chronic obstructive pulmonary disease in a subject in need comprising:
- (a) administering a Receptor Switcher to the subject, wherein the Receptor Switcher is naltrexone in an amount of about 1 microgram to about 500 micrograms;
- and
- (b) administering an Endorphin Enhancer, wherein the Endorphin Enhancer is selected from the group consisting of theophylline, roflumilast, ibudilast, cilomilast, zaprinast, rolipram, methylxanthine.
Dependencies are inferred from the claim text.